These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34467534)

  • 41. Dominant-negative p38alpha mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus.
    Thandavarayan RA; Watanabe K; Ma M; Gurusamy N; Veeraveedu PT; Konishi T; Zhang S; Muslin AJ; Kodama M; Aizawa Y
    Am J Physiol Heart Circ Physiol; 2009 Sep; 297(3):H911-9. PubMed ID: 19617408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TBC1D25 Regulates Cardiac Remodeling Through TAK1 Signaling Pathway.
    Guo S; Liu Y; Gao L; Xiao F; Shen J; Xing S; Yang F; Zhang W; Shi Q; Li Y; Zhao L
    Int J Biol Sci; 2020; 16(8):1335-1348. PubMed ID: 32210723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. G(13)-mediated signaling pathway is required for pressure overload-induced cardiac remodeling and heart failure.
    Takefuji M; Wirth A; Lukasova M; Takefuji S; Boettger T; Braun T; Althoff T; Offermanns S; Wettschureck N
    Circulation; 2012 Oct; 126(16):1972-82. PubMed ID: 22972902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
    Li CJ; Lv L; Li H; Yu DM
    Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dapagliflozin Attenuates Cardiac Remodeling in Mice Model of Cardiac Pressure Overload.
    Shi L; Zhu D; Wang S; Jiang A; Li F
    Am J Hypertens; 2019 Apr; 32(5):452-459. PubMed ID: 30689697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction.
    Liu YH; Carretero OA; Cingolani OH; Liao TD; Sun Y; Xu J; Li LY; Pagano PJ; Yang JJ; Yang XP
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2616-23. PubMed ID: 16055518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional brown adipose tissue limits cardiomyocyte injury and adverse remodeling in catecholamine-induced cardiomyopathy.
    Thoonen R; Ernande L; Cheng J; Nagasaka Y; Yao V; Miranda-Bezerra A; Chen C; Chao W; Panagia M; Sosnovik DE; Puppala D; Armoundas AA; Hindle A; Bloch KD; Buys ES; Scherrer-Crosbie M
    J Mol Cell Cardiol; 2015 Jul; 84():202-11. PubMed ID: 25968336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.
    Salvador AM; Nevers T; Velázquez F; Aronovitz M; Wang B; Abadía Molina A; Jaffe IZ; Karas RH; Blanton RM; Alcaide P
    J Am Heart Assoc; 2016 Mar; 5(3):e003126. PubMed ID: 27068635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis.
    Marini F; Falchetti A; Silvestri S; Bagger Y; Luzi E; Tanini A; Christiansen C; Brandi ML
    Curr Med Res Opin; 2008 Sep; 24(9):2609-15. PubMed ID: 18687167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Farnesyl diphosphate synthase promotes cell proliferation by regulating gene expression and alternative splicing profiles in HeLa cells.
    Wang L; Chen Z; Chen D; Kan B; He Y; Cai H
    Oncol Lett; 2023 Apr; 25(4):145. PubMed ID: 36936029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of farnesyl pyrophosphate synthase prevents angiotensin II-induced cardiac fibrosis in vitro.
    Li Z; Bi X; Wang M; Zhang J; Song J; Shen X; Han J; Fu G; Ye Y
    Clin Exp Immunol; 2014 Jun; 176(3):429-37. PubMed ID: 24527834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac-specific deletion of SOCS-3 prevents development of left ventricular remodeling after acute myocardial infarction.
    Oba T; Yasukawa H; Hoshijima M; Sasaki K; Futamata N; Fukui D; Mawatari K; Nagata T; Kyogoku S; Ohshima H; Minami T; Nakamura K; Kang D; Yajima T; Knowlton KU; Imaizumi T
    J Am Coll Cardiol; 2012 Feb; 59(9):838-52. PubMed ID: 22361405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Approaches for Designing new Potent Inhibitors of Farnesyl Pyrophosphate Synthase.
    Rodriguez JB; Falcone BN; Szajnman SH
    Expert Opin Drug Discov; 2016; 11(3):307-20. PubMed ID: 26781029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibiting mevalonate pathway enzymes increases stromal cell resilience to a cholesterol-dependent cytolysin.
    Griffin S; Preta G; Sheldon IM
    Sci Rep; 2017 Dec; 7(1):17050. PubMed ID: 29213055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deletion of Microfibrillar-Associated Protein 4 Attenuates Left Ventricular Remodeling and Dysfunction in Heart Failure.
    Wang HB; Yang J; Shuai W; Yang J; Liu LB; Xu M; Tang QZ
    J Am Heart Assoc; 2020 Sep; 9(17):e015307. PubMed ID: 32856514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FABP5 Deficiency Impairs Mitochondrial Function and Aggravates Pathological Cardiac Remodeling and Dysfunction.
    Gao S; Li G; Shao Y; Wei Z; Huang S; Qi F; Jiao Y; Li Y; Zhang C; Du J
    Cardiovasc Toxicol; 2021 Aug; 21(8):619-629. PubMed ID: 33929718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling.
    Nguyen MN; Ziemann M; Kiriazis H; Su Y; Thomas Z; Lu Q; Donner DG; Zhao WB; Rafehi H; Sadoshima J; McMullen JR; El-Osta A; Du XJ
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H45-H60. PubMed ID: 30387702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of Rab prenylation by statins induces cellular glycosphingolipid remodeling.
    Binnington B; Nguyen L; Kamani M; Hossain D; Marks DL; Budani M; Lingwood CA
    Glycobiology; 2016 Feb; 26(2):166-80. PubMed ID: 26405105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Manipulation of cardiac phosphatidylinositol 3-kinase (PI3K)/Akt signaling by apoptosis regulator through modulating IAP expression (ARIA) regulates cardiomyocyte death during doxorubicin-induced cardiomyopathy.
    Kitamura Y; Koide M; Akakabe Y; Matsuo K; Shimoda Y; Soma Y; Ogata T; Ueyama T; Matoba S; Yamada H; Ikeda K
    J Biol Chem; 2014 Jan; 289(5):2788-800. PubMed ID: 24338479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
    Wu MP; Zhang YS; Xu X; Zhou Q; Li JD; Yan C
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):157-166. PubMed ID: 28321644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.